UPLOAD Filing
Enveric Biosciences, Inc.
Date: Feb. 17, 2026 · CIK: 0000890821 · Accession: 0000000000-26-001615
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293327
Letter
February 17, 2026 Joseph Tucker Chief Executive Officer Enveric Biosciences, Inc. 245 First Street, Riverview II, 18th Floor Cambridge, MA 02142 Re:Enveric Biosciences, Inc. Registration Statement on Form S-1 Filed February 10, 2026 File No. 333-293327 Dear Joseph Tucker: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Brad Wyatt
Show Raw Text
February 17, 2026
Joseph Tucker
Chief Executive Officer
Enveric Biosciences, Inc.
245 First Street, Riverview II, 18th Floor
Cambridge, MA 02142
Re:Enveric Biosciences, Inc.
Registration Statement on Form S-1
Filed February 10, 2026
File No. 333-293327
Dear Joseph Tucker:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Brad Wyatt